SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Monogram Biosciences, Inc. (Nasdaq:MGRM) today announced that several presentations will be made at the CTRC-AACR San Antonio Breast Cancer Symposium, to be held at the Henry B. Gonzalez Convention Center, December 10-14 in San Antonio, Texas. The presentations will discuss Monogram’s HERmark™ Breast Cancer Assay and the VeraTag™ technology platform. Following are the embargoed presentations:
